Dhg Pharmaceutical Joint-Stock Co operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dhg Pharmaceutical Joint-Stock Co with three other
companies in this sector in Vietnam:
DOMESCO Medical Import Export Joint Stock Corp
(2018
sales of 1.39 trillion Dong [US$59.70 million]
),
Hatay Pharmaceutical JSC
(1.71 trillion Dong [US$73.50 million]
), and
Traphaco JSC
(1.80 trillion Dong [US$77.51 million]
of which 100%
was Pharmacy).
Sales Analysis.
Dhg Pharmaceutical Joint-Stock Co reported sales of 3.88 trillion Dong (US$167.32 million)
for the
year ending
December of 2018.
This
represents
a
decrease of 4.4%
versus 2017, when the company's sales were 4.06 trillion Dong.
Contributing to the drop in overall sales was the 43.9% decline
in Other Activities, from 340.33 billion Dong to 191.01 billion Dong.
There were also decreases in sales in
Medicine (down 0.9% to 3.31 trillion Dong)
and
Supplements (down 0.3% to 377.75 billion Dong)
.